Webinar | July 6, 2023

Reshaping Decentralized Clinical Trials With Fit-For-Patient Solutions

Source: Marken, a UPS company
GettyImages-1278800031 diverse trial participants

New pathways to clinical trial design are enabling more reliable, effective trials, helping to advance drug products to commercialization with fewer delays and risks. Decentralized trials are offering a more patient-centric experience for clinical trials and helping sponsors overcome notable hurdles common to traditional trials.

Recruitment challenges have afflicted the clinical trials space for years, often resulting in costly delays on the path to commercialization and preventing patients from receiving life-saving treatments in a timely manner. Patient retention is also a common challenge for clinical trial sponsors, as patients often find the demands of the trials more burdensome than beneficial. Decentralized trials enable patients to participate and receive medical treatments in their own home, lowering barriers to recruitment and retention. These innovative trials also increase the quality of trial data collected as the ease of participation often results in improved study engagement.

Learn more about the potential of decentralized trials as well as the technological and regulatory challenges which need to be considered in order to achieve success.

access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader